| Ident. | Authors (with country if any) | Title |
|---|
| 000220 |
Moonhee Lee ; Edith G. Mcgeer ; Patrick L. Mcgeer [Canada] | Quercetin, not caffeine, is a major neuroprotective component in coffee. |
| 000364 |
Yan Xu [République populaire de Chine] ; Yanyan Zhang [République populaire de Chine] ; Zhenzhen Quan [République populaire de Chine] ; Winnie Wong [Canada] ; Jianping Guo [Canada] ; Rongkai Zhang [République populaire de Chine] ; Qinghu Yang [République populaire de Chine] ; Rongji Dai [République populaire de Chine] ; Patrick L. Mcgeer [Canada] ; Hong Qing [République populaire de Chine] | Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson's Disease. |
| 000F69 |
Moonhee Lee [Canada] ; Edith Mcgeer [Canada] ; Ravinder Kodela [États-Unis] ; Khosrow Kashfi [États-Unis] ; Patrick L. Mcgeer [Canada] | NOSH‐aspirin (NBS‐1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: A new candidate for treatment of neurodegenerative disorders |
| 001107 |
Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ |
| 001638 |
Moonhee Lee [Canada] ; Nattinee Jantaratnotai ; Edith Mcgeer ; James G. Mclarnon ; Patrick L. Mcgeer | Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels. |
| 001654 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | History of Innate Immunity in Neurodegenerative Disorders |
| 001936 |
Moonhee Lee [Canada] ; Nattinee Jantaratnotai [Canada] ; Edith Mcgeer [Canada] ; James G. Mclarnon [Canada] ; Patrick L. Mcgeer [Canada] | Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels |
| 001A65 |
Sadayuki Hashioka [Canada] ; Andis Klegeris ; Claudia Schwab ; Sheng Yu ; Patrick L. Mcgeer | Differential expression of interferon-gamma receptor on human glial cells in vivo and in vitro. |
| 001C16 |
Jun Liu [République populaire de Chine, États-Unis] ; Min Shi [États-Unis] ; Zhen Hong [République populaire de Chine] ; Jianpeng Zhang [États-Unis] ; Joshua Bradner [États-Unis] ; Thomas Quinn [États-Unis] ; Richard P. Beyer [États-Unis] ; Patrick L. Mcgeer [Canada] ; Shengdi Chen [République populaire de Chine] ; Jing Zhang [États-Unis] | Identification of ciliary neurotrophic factor receptor α as a mediator of neurotoxicity induced by α‐synuclein |
| 001C17 |
Moonhee Lee [Canada] ; Anna Sparatore [Italie] ; Piero Del Soldato [Italie] ; Edith Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Hydrogen sulfide‐releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation |
| 001D07 |
JUN LIU [République populaire de Chine, États-Unis] ; MIN SHI [États-Unis] ; ZHEN HONG [République populaire de Chine] ; JIANPENG ZHANG [États-Unis] ; Joshua Bradner [États-Unis] ; Thomas Quinn [États-Unis] ; Richard P. Beyer [États-Unis] ; Patrick L. Mcgeer [Canada] ; SHENGDI CHEN [République populaire de Chine] ; JING ZHANG [États-Unis] | Identification of ciliary neurotrophic factor receptor α as a mediator of neurotoxicity induced by α-synuclein |
| 001E23 |
Hong Qing [Canada] ; Winnie Wong ; Edith G. Mcgeer ; Patrick L. Mcgeer | Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications. |
| 001E78 |
Moonhee Lee [Canada] ; Claudia Schwab ; Sheng Yu ; Edith Mcgeer ; Patrick L. Mcgeer | Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. |
| 002090 |
Sadayuki Hashioka [Canada] ; Andis Klegeris [Canada] ; Claudia Schwab [Canada] ; Patrick L. Mcgeer [Canada] | Interferon-γ-dependent cytotoxic activation of human astrocytes and astrocytoma cells |
| 002119 |
Moonhee Lee [Canada] ; Claudia Schwab [Canada] ; SHENG YU [Canada] ; Edith Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide |
| 002135 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer | The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease. |
| 002199 |
Judith Miklossy [Canada] ; John C. Steele ; Sheng Yu ; Sherman Mccall ; Glenn Sandberg ; Edith G. Mcgeer ; Patrick L. Mcgeer | Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). |
| 002285 |
Andis Klegeris [Canada] ; Jane Li [États-Unis] ; Theo K. Bammler [États-Unis] ; Jinghua Jin [États-Unis] ; David Zhu [États-Unis] ; Daniel T. Kashima [États-Unis] ; Sheng Pan [États-Unis] ; Sadayuki Hashioka [Canada] ; John Maguire [Canada] ; Patrick L. Mcgeer [Canada] ; Jing Zhang [États-Unis] | Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP‐1 cell neurotoxicity |
| 002317 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Glial reactions in Parkinson's disease |
| 002374 |
John C. Steele ; Patrick L. Mcgeer [Canada] | The ALS/PDC syndrome of Guam and the cycad hypothesis |
| 002425 |
Andis Klegeris [Canada] ; Edith G. Mcgeer ; Patrick L. Mcgeer | Therapeutic approaches to inflammation in neurodegenerative disease. |
| 002480 |
Andis Klegeris [Canada] ; Patrick L. Mcgeer | Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112. |
| 002559 |
Wei Zhang [États-Unis, République populaire de Chine] ; Shannon Dallas [États-Unis] ; Dan Zhang [États-Unis] ; Jian-Ping Guo [Canada] ; Hao Pang [États-Unis] ; Belinda Wilson [États-Unis] ; David S. Miller [États-Unis] ; Biao Chen [République populaire de Chine] ; Wanqin Zhang [République populaire de Chine] ; Patrick L. Mcgeer [Canada] ; Jau-Shyong Hong [États-Unis] ; Jing Zhang [États-Unis] | Microglial PHOX and Mac‐1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha‐synuclein |
| 002627 |
Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | The role of anti-inflammatory agents in Parkinson's disease |
| 002758 |
Andis Klegeris [Canada] ; Benoit I. Giasson ; Hong Zhang ; John Maguire ; Steven Pelech ; Patrick L. Mcgeer | Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. |
| 002919 |
Judith Miklossy [Canada] ; Tetsuaki Arai [Japon] ; Jian-Ping Guo [Canada] ; Andis Klegeris [Canada] ; SHENG YU [Canada] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | LRRK2 expression in normal and pathologic human brain and in human cell lines |
| 002A55 |
A. Jon Stoessl [Canada] ; Patrick L. Mcgeer [Canada] | Hot spots: Can positron emission tomography offer insights into the pathogenesis of PD? |
| 002A70 |
Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | Chymotrypsin‐like proteases contribute to human monocytic THP‐1 cell as well as human microglial neurotoxicity |
| 002B20 |
Edith G. Mcgeer [Canada] ; Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | Inflammation, the complement system and the diseases of aging |
| 002B78 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer | Inflammation and neurodegeneration in Parkinson's disease. |
| 002C59 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Inflammation and the Degenerative Diseases of Aging |
| 002E38 |
Patrick L. Mcgeer [Canada] ; Claudia Schwab ; Andre Parent [Canada] ; Doris Doudet | Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration |
| 002F72 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer | Innate immunity, local inflammation, and degenerative disease. |
| 003096 |
Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity |
| 003101 |
Patrick L. Mcgeer [Canada] ; Koji Yasojima [Canada] ; Edith G. Mcgeer [Canada] | Association of interleukin-1β polymorphisms with idiopathic Parkinson's disease |
| 003141 |
Koji Yasojima [Canada] ; Claudia Schwab [Canada] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques |
| 003309 |
Patrick L. Mcgeer [Canada] ; Koji Yasojima [Canada] ; Edith G. Mcgeer [Canada] | Inflammation in Parkinson's disease |
| 003453 |
Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | R -(−)-Deprenyl Inhibits Monocytic THP-1 Cell Neurotoxicity Independently of Monoamine Oxidase Inhibition |
| 003528 |
Claudia Schwab [Canada] ; Anthony J. Demaggio [États-Unis] ; Nupur Ghoshal [États-Unis] ; Lester I. Binder [États-Unis] ; Jeff Kuret [États-Unis] ; Patrick L. Mcgeer [Canada] | Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases |
| 003729 |
Claudia Schwab [Canada] ; Michael Schulzer [Canada] ; John C. Steele ; Patrick L. Mcgeer [Canada] | On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam |
| 003878 |
Douglas G. Walker [Canada] ; Thomas G. Beach [Canada, États-Unis] ; Ren Xu [États-Unis] ; Jack Lile [États-Unis] ; Klaus D. Beck [États-Unis] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease |
| 003930 |
Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | The importance of inflammatory mechanisms in alzheimer disease |
| 003976 |
Douglas G. Walker [Canada, États-Unis] ; Kazuhiro Terai [Canada, Japon] ; Akinori Matsuo [Canada, Japon] ; Thomas G. Beach [Canada, États-Unis] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases |
| 003C10 |
Patrick L. Mcgeer [Canada] ; Douglas G. Walker [Canada] ; Robert E. Pitas [États-Unis] ; Robert W. Mahley [États-Unis] ; Edith G. Mcgeer [Canada] | Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates β-amyloid protein activation of complement in vitro |
| 003D27 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases |
| 003D50 |
Osamu Yasuhara [Canada, Japon] ; Claudia Schwab [Canada] ; Akinori Matsuo [Canada] ; Seung U. Kim [Canada] ; John C. Steele ; Ichiro Akiguchi [Japon] ; Jun Kimura [Japon] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Midkine-like immunoreactivity in extracellular neurofibrillary tangles in brains of patients with parkinsonism-dementia complex of Guam |
| 003E25 |
Claudia Schwab [Canada] ; John C. Steele ; Patrick L. Mcgeer [Canada] | Neurofibrillary tangles of Guam parkinson-dementia are associated with reactive microglia and complement proteins |
| 003F56 |
Ryan J. Uitti [Canada] ; Kenneth Berry [Canada] ; Osamu Yasuhara [Canada] ; Andrew Eisen [Canada] ; Howard Feldman [Canada] ; Patrick L. Mcgeer [Canada] ; Donald B. Calne [Canada] | Neurodegenerative ‘overlap’ syndrome: Clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's disease |
| 004013 |
Claudia Schwab [Canada] ; John C. Steele ; Haruhiko Akiyama [Japon] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Relationship of amyloid β/A4 protein to the neurofibrillary tangles in Guamanian parkinsonism-dementia |
| 004486 |
Edith G. Mcgeer [Canada] ; Edith A. Singh [Canada] ; Patrick L. Mcgeer [Canada] | Apparent anterograde transport of basic fibroblast growth factor in the rat nigrostriatal dopamine system |
| 004E23 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] ; Kamo Hisaki [Canada] ; Kathy Wong [Canada] | Positron emission tomography and the possible origins of cytopathology in Alzheimer's disease |
| 005418 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Neurotransmitter synthetic enzymes |
